Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.415 USD | +2.77% | +2.77% | +8.30% |
May. 08 | Earnings Flash (SCYX) SCYNEXIS Reports Q1 Revenue $1.4M | MT |
May. 08 | SCYNEXIS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 29
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Medicines
100.0
%
| 5 | 100.0 % | 140 | 100.0 % | +2,652.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 5 | 100.0 % | 140 | 100.0 % | +2,652.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 15-05-31 | |
Ivor MacLeod
DFI | Director of Finance/CFO | 63 | 22-10-23 |
Daniella Gigante
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-30 |
Scott Sukenick
LAW | General Counsel | 46 | 17-11-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Armando Anido
BRD | Director/Board Member | 66 | 19-01-20 |
David Hastings
BRD | Director/Board Member | 62 | 15-09-23 |
Ann Hanham
BRD | Director/Board Member | 71 | 08-11-30 |
Guy MacDonald
CHM | Chairman | 65 | 14-11-26 |
Steven Gilman
BRD | Director/Board Member | 71 | 15-02-24 |
Chief Executive Officer | 59 | 15-05-31 | |
Brian Tinmouth
BRD | Director/Board Member | 60 | 19-12-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,779,796 | 37,473,680 ( 99.19 %) | 0 | 99.19 % |
Company contact information
SCYNEXIS, Inc.
1 Evertrust Plaza 13th floor
07302-6548, Jersey City
+201 884 5485
http://www.scynexis.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.30% | 91.24M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- SCYX Stock
- Company SCYNEXIS, Inc.